Patents by Inventor Beatrix Fyrnys

Beatrix Fyrnys has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
    Patent number: 8268864
    Abstract: Pharmaceutical compositions comprising an anticholinergic and at least one leukotriene inhibitor for treatment of respiratory diseases, including allergic rhinitis, bronchial asthma, COPD and common cold, and methods of treatment.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: September 18, 2012
    Assignee: Meda Pharma GmbH & Co. KG
    Inventors: Beatrix Fyrnys, Torsten Hoffmann, Mario Weingart, Istvan Szelenyi, Peter Jurgen Cnota, Ullrich Munzel, Ursula Petzold, Joachim Maus
  • Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease
    Patent number: 8097605
    Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
    Type: Grant
    Filed: February 3, 2009
    Date of Patent: January 17, 2012
    Assignee: Meda Pharma GmbH & Co. KG
    Inventors: Joachim Maus, Peter Juergen Cnota, Istvan Szelenyi, Beatrix Fyrnys
  • Combination of Anticholinergics and Inhibitors of Phosphodiesterase Type 4 For The Treatment of Respiratory Disease
    Publication number: 20090136429
    Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R, R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
    Type: Application
    Filed: February 3, 2009
    Publication date: May 28, 2009
    Inventors: Joachim Maus, Peter Juergen Cnota, Istvan Szelenyi, Beatrix Fyrnys
  • Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
    Publication number: 20060251589
    Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
    Type: Application
    Filed: July 13, 2006
    Publication date: November 9, 2006
    Applicant: Sofotec GmbH & Co. KG
    Inventors: Joachim Maus, Peter Cnota, Istvan Szelenyi, Beatrix Fyrnys
  • Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
    Publication number: 20060211729
    Abstract: Pharmaceutical compositions comprising an anticholinergic and at least one leukotriene inhibitor for treatment of respiratory diseases, including allergic rhinitis, bronchial asthma, COPD and common cold, and methods of treatment.
    Type: Application
    Filed: March 16, 2006
    Publication date: September 21, 2006
    Applicant: MEDA Pharma GmbH & Co. KG
    Inventors: Beatrix Fyrnys, Torsten Hoffmann, Mario Weingart, Istvan Szelenyi, Peter Cnota, Ullrich Munzel, Ursula Petzold, Joachim Maus
  • Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
    Publication number: 20050175547
    Abstract: The present invention relates to a combination of an inhaled/oral PDE 4 inhibitor in combination with inhaled anticholinergic bronchodilators (muscarinic receptor antagonists), preferentially Roflumilast or AWD-12-281 and R,R-glycopyrrolate, for symptomatic or prophylactic treatment of respiratory diseases, especially those accompanied by obstruction or inflammation such as chronic obstructive pulmonary disease (COPD) or asthma. It further comprises the presentation of this combination in a locally applied (inhaled) formulation and application in an inhalation device for instance in the Novolizer®.
    Type: Application
    Filed: February 7, 2005
    Publication date: August 11, 2005
    Applicant: Sofotec GmbH & Co. KG
    Inventors: Joachim Maus, Peter Cnota, Istvan Szelenyi, Beatrix Fyrnys